⌘K
Loading ticker…
ALPS Medical Breakthroughs ETF · Other
3m RS is unavailable, Market Stance is 49.9
As of 2026-08-21, ALPS Medical Breakthroughs ETF (SBIO) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 49.9 (Neutral). Sector: Other. Average daily range 2.2%, relative volume 1.30×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | ALKS | 4.48% | $7M |
| 2 | KYMR | 4.23% | $7M |
| 3 | CELC | 3.92% | $6M |
| 4 | MIRM | 3.90% | $6M |
| 5 | SYRE | 3.68% | $6M |
| 6 | CGON | 3.35% | $5M |
| 7 | APGE | 2.93% | $5M |
| 8 | XENE | 2.90% | $5M |
| 9 | TVTX | 2.77% | $4M |
| 10 | DNTH | 2.64% | $4M |
| 11 | NAMS | 2.47% | $4M |
| 12 | VKTX | 2.41% | $4M |
| 13 | CRNX | 2.37% | $4M |
| 14 | ACAD | 2.35% | $4M |
| 15 | EWTX | 2.33% | $4M |
| 16 | DNLI | 2.13% | $3M |
| 17 | ORKA | 1.81% | $3M |
| 18 | Structure Therapeutics Inc | 1.78% | $3M |
| 19 | IRON | 1.69% | $3M |
| 20 | IDYA | 1.65% | $3M |
| 21 | VERA | 1.61% | $3M |
| 22 | TARS | 1.61% | $3M |
| 23 | RLAY | 1.60% | $3M |
| 24 | MLYS | 1.59% | $3M |
| 25 | CLDX | 1.33% | $2M |
Showing 25 of 82 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SBIO Jan avg: 2.00% median: 0.40% win: 75% σ: 3.51% n: 4 2022-04-12 → 2026-07-31 | SBIO Feb avg: 0.02% median: -2.27% win: 50% σ: 8.40% n: 4 2022-04-12 → 2026-07-31 | SBIO Mar avg: -5.29% median: -6.23% win: 25% σ: 5.40% n: 4 2022-04-12 → 2026-07-31 | SBIO Apr avg: -1.39% median: 2.43% win: 60% σ: 10.28% n: 5 2022-04-12 → 2026-07-31 | SBIO May avg: -0.40% median: 1.55% win: 60% σ: 5.88% n: 5 2022-04-12 → 2026-07-31 | SBIO Jun avg: 5.88% median: 3.22% win: 60% σ: 7.92% n: 5 2022-04-12 → 2026-07-31 | SBIO Jul avg: 5.46% median: 7.76% win: 80% σ: 5.56% n: 5 2022-04-12 → 2026-07-31 | SBIO Aug avg: 1.40% median: 3.00% win: 50% σ: 6.42% n: 4 2022-04-12 → 2026-07-31 (current) | SBIO Sep avg: -0.49% median: -2.53% win: 25% σ: 8.73% n: 4 2022-04-12 → 2026-07-31 | SBIO Oct avg: 2.36% median: 1.54% win: 75% σ: 10.65% n: 4 2022-04-12 → 2026-07-31 | SBIO Nov avg: 5.63% median: 5.10% win: 100% σ: 4.06% n: 4 2022-04-12 → 2026-07-31 | SBIO Dec avg: 2.49% median: -0.08% win: 50% σ: 16.79% n: 4 2022-04-12 → 2026-07-31 |
Metrics matched 80 tickers across 82 holdings rows (97.4% of fund weight). Metrics as of 2026-08-21; holdings from the filing.
Position changes from the to the N-PORT filing.
| Holding | Before → after | Δ weight |
|---|---|---|
| SYRESpyre Therapeutics Inc | 2.15% → 3.68% | +1.52 pp |
| ALKSAlkermes Plc | 3.21% → 4.48% | +1.27 pp |
| DNTHDianthus Therapeutics Inc | 1.53% → 2.64% | +1.11 pp |
| TVTXTravere Therapeutics Inc | 1.72% → 2.77% | +1.05 pp |
| MIRMMirum Pharmaceuticals Inc | 3.06% → 3.90% | +0.84 pp |
+32 more
| Holding | Before → after | Δ weight |
|---|---|---|
| Structure Therapeutics Inc | 2.47% → 1.78% | −0.69 pp |
| MAZEMaze Therapeutics Inc | 1.42% → 0.81% | −0.61 pp |
| OLMAOlema Pharmaceuticals Inc | 1.23% → 0.66% | −0.57 pp |
| TARSTarsus Pharmaceuticals Inc | 2.07% → 1.61% | −0.46 pp |
| KYMRKymera Therapeutics Inc | 4.66% → 4.23% | −0.42 pp |
+34 more
| Holding | Before → after | Δ weight |
|---|---|---|
| Amicus Therapeutics Inc | 2.86% → — | — |
| Apellis Pharmaceuticals Inc | 1.71% → — | — |
| Day One Biopharmaceuticals Inc | 0.70% → — | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Holdings of SBIO currently on TickerStance stock-RS leaderboards.